Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Tuberous Sclerosis 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphangioleiomyomatosis 1HER2-positive Breast Cancer 1Colorectal Neoplasms 1Breast Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Letrozole 26Fulvestrant 25Specimen Handling 20ribociclib 17Paclitaxel 16Capecitabine 16pembrolizumab 15palbociclib 15Trastuzumab 14Carboplatin 14exemestane 13abemaciclib 12Tamoxifen 12Anastrozole 12Magnetic Resonance Spectroscopy 11pertuzumab 9trastuzumab deruxtecan 8Biopsy 8Goserelin 7inavolisib 6giredestrant 6elacestrant 6Radiotherapy 6Cyclophosphamide 6130-nm albumin-bound paclitaxel 6patritumab deruxtecan 5eribulin 5Taxes 5Standard of Care 5Gonadotropin-Releasing Hormone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Genetic Testing × 30 days × Clear all
NCT05649072 2026-05-22

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

M.D. Anderson Cancer Center

Phase NA Recruiting
1,000 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡